Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development | White Papers
Search Refinements

Drug Discovery & Development White Papers

View white papers from other Pharmaceutical sectors:
76-90 of 140 results
7th DIA/EFGCP/EMA Medicines for Children Conference, 24th-25th September 2013, London, UK
| By Drug Information Association
This year’s DIA/EFGCP/EMA paediatric conference will take place in the seventh year of the EU Paediatric Regulation. Over 1’000 Paediatric Investigation Plans (PIPs) have been submitted so far and paediatric aspects are now an integrated part of drug development.
Drug Research > Drug Discovery & Development > White Papers
Joint DIA/MHRA Statistics Workshop 2nd-4th October 2013, London, United Kingdom
| By Drug Information Association
Life-cycle management is a widely accepted concept for the development and marketing of medicines. At each step of this process, pre- and post-licensing, statisticians work to develop methods that can improve efficiency and can enhance decision-making through optimal study design, analysis and inference. The workshop aims to discuss the latest developments in statistical methodology and decision-making in exploratory development, confirmatory development, licensing decisions and management of benefits and risks post-licensing.
Drug Research > Drug Discovery & Development > White Papers
7th Annual DIA Clinical Forum Dublin, Ireland on 8–9 October 2013.
| By Drug Information Association
The DIA Clinical Forum is known as a conference that brings together experts from different fields, including data management, clinical operations, drug safety, medical affairs, medical information and medical writing. Experts share their expertise and experience with people from other companies and disciplines. Making the presentations and workshops relevant to the day to day work of participants has always been the focus of previous programme committees – and I am glad to confirm that this won’t be any different this year.
Drug Research > Drug Discovery & Development > White Papers
10th Middle East Regulatory Conference (MERC) 2013. Collaboration, Partnership and Interaction: Authority and Industry
| By Drug Information Association
This is the 10th DIA Middle East Regulatory Conference in partnership with the Middle East Regulatory Network (MERN). The MERN is an ad hoc regional network of the EFPIA (European Federation of Pharmaceutical Industries and Associations). The MERN works in partnership with regulatory authorities and the pharmaceutical industry in the Middle East to develop legislation and regulatory practices that enable patients to have access to good quality medicines, including innovative medicines.
Drug Research > Drug Discovery & Development > White Papers
26th Annual EuroMeeting Vienna 2014, 25th - 27th March 2014 ACV, Vienna, Austria
| By Drug Information Association
The Annual EuroMeeting is DIA’s largest conference in Europe, attracting more than 3,000 professionals from industry, government, academia, as well as patient groups and students. It is unique in the quality of its content and speakers, and in the opportunity to network with like minded professionals, regulators and thought leaders. Early-bird rate for DIA Members – register by Tuesday, 11 February 2014 and save €185! Register onsite at DIA 2013 to save an additional €100!
Drug Research > Drug Discovery & Development > White Papers
IMD-A Systems: Ideal Training Tools
| By Azbil BioVigilant
Many pharmaceutical, biotechnology, ophthalmology and food and beverage companies manufacture and package their products in cleanrooms or other highly controlled environments using operating procedures designed to minimize contamination of products with foreign materials. Microbial contamination, in particular, is a serious concern because of the potential danger to the health of recipients.
Drug Research > Drug Discovery & Development > White Papers
Real-Time Investigation Services Using Instantaneous Microbial Detection
| By Azbil BioVigilant
In the pharmaceutical industry, product contamination poses a serious risk to manufacturing operations. If an out-of-specification event occurs, finding the root cause, taking remediation steps, and getting the manufacturing line back to full operational levels is critically important. Downtime on any manufacturing line can lead to a significant impact on the financial performance of the company.
Drug Research > Drug Discovery & Development > White Papers
Instantaneous Microbial Monitoring of Compressed Gases
| By Azbil BioVigilant
Compressed air and other gases are used for a range of applications in pharmaceutical and food and beverage manufacturing, including applications involving direct product contact. As such, these gases should be monitored for levels of microbial and particulate contamination. Azbil BioVigilant’s IMD-A® systems are useful tools for microbial monitoring that offer the advantages of increased sensitivity, instantaneous detection, and real-time reporting, as compared to traditional growth-based methods.
Drug Research > Drug Discovery & Development > White Papers
A short history of cell culture media and the use of insulin
| By Novo Nordisk Pharmatech A/S
The ancestors of cell culture media were the balanced salt solutions (BSS) devised by early workers interested in studying isolated organs ex vivo. The first BSS was composed in 1885 by Sydney Ringer (1836-1910), a British clinician and pharmacologist from University College London who worked on the isolated frog heart.
Drug Research > Drug Discovery & Development > White Papers
Introduction of Pierre de Meyts. MD, PhD, F.A.C.E
| By Novo Nordisk Pharmatech A/S
Pierre de Meyts is an expert who has worked with and researched insulin and receptor binding for almost half a century. FeF Chemicals A/S is proud to present what we assume to be one of the best pieces describing the functionality of insulin and insulin like growth factors, with respect to receptor binding and cellular response.
Drug Research > Drug Discovery & Development > White Papers
SOLUTIONS IN QUATS THAT FIT YOUR REQUIREMENTS cGMP Pharmaceutical Grade APIs & Excipients
| By Novo Nordisk Pharmatech A/S
FeF Chemicals is the worldwide leading supplier of high quality Quaternary Ammonium Compounds (quats). We are specialized in the pharmaceutical and personal care industries, providing quats of global regulatory compliance. We provide only the very best and safest ingredients for your formulation, preserving its quality and contributing to patient safety.
Drug Research > Drug Discovery & Development > White Papers
Smart HPLC Solutions for Large Molecules
| By Tosoh Bioscience
The biopharmaceutical research sector and its products represent a significant area of growth for today’s pharmaceutical industry. Major biotherapeutic categories currently include vaccines, therapeutic proteins such as growth factors or cytokines, and, last but not least, monoclonal antibodies. A thorough characterisation of these products is a key task for the successful submission of data for their regulatory approval.
Drug Research > Drug Discovery & Development > White Papers
TOYOPEARL gigaCap® Series
| By Tosoh Bioscience
ion exchange Chromatography (iEC) is one of the most frequently used chromatographic modes for the separation and purifi cation of biomolecules. it is used at all stages and scales of purifi cation of therapeutic proteins: from laboratory scale purifi cation to industrial scale downstream processing (dSP). toyopearl media are hydrophilic, macroporous polymethacrylate resins, available with various ligands and in different particle and pore sizes.
Drug Research > Drug Discovery & Development > White Papers
76-90 of 140 results